Item Type | Name |
Academic Article
|
Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
|
Academic Article
|
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
|
Academic Article
|
Targeting SRC in mucinous ovarian carcinoma.
|
Academic Article
|
Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors.
|
Academic Article
|
Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.
|
Concept
|
Transgenes
|
Concept
|
Genes, Reporter
|
Concept
|
Gene Expression Regulation, Enzymologic
|
Concept
|
Gene Expression Profiling
|
Concept
|
Genes, MDR
|
Concept
|
Gene Amplification
|
Concept
|
Gene Regulatory Networks
|
Concept
|
Genes, BRCA1
|
Concept
|
Genes, Tumor Suppressor
|
Concept
|
Oncogenes
|
Concept
|
Gene Expression
|
Concept
|
Open Reading Frames
|
Concept
|
Amino Acid Sequence
|
Concept
|
Catalytic Domain
|
Concept
|
Genome, Human
|
Concept
|
Gene Targeting
|
Concept
|
Polymorphism, Single Nucleotide
|
Concept
|
Gene Library
|
Concept
|
Genes, myc
|
Concept
|
Gene Expression Regulation, Neoplastic
|
Concept
|
Genes, src
|
Concept
|
Genetic Loci
|
Concept
|
Genes, BRCA2
|
Concept
|
Gene Expression Regulation, Plant
|
Concept
|
Molecular Structure
|
Concept
|
Gene Frequency
|
Concept
|
Gene Deletion
|
Concept
|
Gene Silencing
|
Concept
|
Gene Duplication
|
Concept
|
Gene Knockout Techniques
|
Concept
|
Base Sequence
|
Concept
|
Alleles
|
Concept
|
Gene Knockdown Techniques
|
Concept
|
Gene Transfer Techniques
|
Concept
|
Molecular Sequence Data
|
Concept
|
Genes, ras
|
Concept
|
Gene Expression Regulation
|
Concept
|
Genes, Neoplasm
|
Concept
|
Genes, p53
|
Concept
|
Nucleic Acid Conformation
|
Concept
|
RNA Splice Sites
|
Concept
|
Gene Dosage
|
Academic Article
|
Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.
|
Academic Article
|
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
|
Academic Article
|
Integrated genomic analyses of ovarian carcinoma.
|
Academic Article
|
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.
|
Academic Article
|
Definition of PKC-a, CDK6, and MET as therapeutic targets in triple-negative breast cancer.
|
Academic Article
|
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
|
Academic Article
|
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.
|
Academic Article
|
The complexity of tumor vascularity.
|
Academic Article
|
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
|
Academic Article
|
Location matters.
|
Academic Article
|
Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.
|
Academic Article
|
Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.
|
Academic Article
|
Classification of ovarian cancer: a genomic analysis.
|
Academic Article
|
Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells.
|
Academic Article
|
Dual targeting of EphA2 and FAK in ovarian carcinoma.
|
Academic Article
|
Frequent downregulation of miR-34 family in human ovarian cancers.
|
Academic Article
|
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation.
|
Academic Article
|
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
|
Academic Article
|
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
|
Academic Article
|
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib.
|
Academic Article
|
MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer.
|
Academic Article
|
Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
|
Academic Article
|
An abundance of p53 null mutations in ovarian carcinoma.
|
Academic Article
|
Ovarian cancer genomic instability correlates with p53 frameshift mutations.
|
Academic Article
|
Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
|
Academic Article
|
p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang.
|
Academic Article
|
The paradoxical expression of maspin in ovarian carcinoma.
|
Academic Article
|
Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.
|
Academic Article
|
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome.
|
Academic Article
|
Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
|
Academic Article
|
The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment.
|
Academic Article
|
Sustained small interfering RNA delivery by mesoporous silicon particles.
|
Academic Article
|
Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma.
|
Academic Article
|
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
|
Academic Article
|
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
|
Academic Article
|
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.
|
Academic Article
|
MicroRNA therapeutics: principles, expectations, and challenges.
|
Academic Article
|
Neuropilin-2 mediated ?-catenin signaling and survival in human gastro-intestinal cancer cell lines.
|
Academic Article
|
Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling.
|
Academic Article
|
Genomic DNA copy-number alterations of the let-7 family in human cancers.
|
Academic Article
|
Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.
|
Academic Article
|
Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.
|
Academic Article
|
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer.
|
Academic Article
|
Interleukin-1? promotes ovarian tumorigenesis through a p53/NF-?B-mediated inflammatory response in stromal fibroblasts.
|
Academic Article
|
A new method for stranded whole transcriptome RNA-seq.
|
Academic Article
|
ATP11B mediates platinum resistance in ovarian cancer.
|
Academic Article
|
Tumour angiogenesis regulation by the miR-200 family.
|
Academic Article
|
A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation.
|
Academic Article
|
Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.
|
Academic Article
|
Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance.
|
Academic Article
|
Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
|
Academic Article
|
miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
|
Academic Article
|
Field cancerization: why late "recurrent" ovarian cancer is not recurrent.
|
Academic Article
|
Re: Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer.
|
Academic Article
|
The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma.
|
Academic Article
|
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
|
Academic Article
|
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
|
Academic Article
|
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
|
Academic Article
|
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
|
Academic Article
|
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.
|
Academic Article
|
Concomitant BRCA1 and BRCA2 gene mutations in an Ashkenazi Jewish woman with primary breast and ovarian cancer.
|
Academic Article
|
Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
|
Academic Article
|
EphA2 overexpression promotes ovarian cancer growth.
|
Academic Article
|
Depression, social support, and beta-adrenergic transcription control in human ovarian cancer.
|
Academic Article
|
Liposomal siRNA for ovarian cancer.
|
Academic Article
|
Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats.
|
Academic Article
|
Nanomedicine based approaches for the delivery of siRNA in cancer.
|
Academic Article
|
Computational identification of gene-social environment interaction at the human IL6 locus.
|
Academic Article
|
Regulation of tumor angiogenesis by EZH2.
|
Academic Article
|
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
|
Academic Article
|
Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.
|
Academic Article
|
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer.
|
Academic Article
|
Chitosan hydrogel for localized gene silencing.
|
Academic Article
|
Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.
|
Academic Article
|
Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer.
|
Academic Article
|
MicroRNAs in body fluids--the mix of hormones and biomarkers.
|
Academic Article
|
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.
|
Academic Article
|
Prognostic biomarkers in ovarian cancer.
|
Academic Article
|
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.
|
Academic Article
|
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
|
Academic Article
|
Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer.
|
Academic Article
|
Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.
|
Academic Article
|
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.
|
Academic Article
|
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.
|
Academic Article
|
Poor survival with wild-type TP53 ovarian cancer?
|
Academic Article
|
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.
|
Academic Article
|
The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
|
Academic Article
|
Distant metastases in ovarian cancer: association with p53 mutations.
|
Academic Article
|
Ovarian cancer p53 mutation is associated with tumor microvessel density.
|
Academic Article
|
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
|
Academic Article
|
Dicer, Drosha, and outcomes in patients with ovarian cancer.
|
Academic Article
|
Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
|
Academic Article
|
Integrated analysis of gene expression and tumor nuclear image profiles associated with chemotherapy response in serous ovarian carcinoma.
|
Academic Article
|
Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.
|
Academic Article
|
Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells.
|
Academic Article
|
Notch3 pathway alterations in ovarian cancer.
|
Academic Article
|
p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.
|
Academic Article
|
EphA2 as a target for ovarian cancer therapy.
|
Academic Article
|
Targeted gene silencing using RGD-labeled chitosan nanoparticles.
|
Academic Article
|
Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
|
Academic Article
|
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment.
|
Academic Article
|
TP53 loss creates therapeutic vulnerability in?colorectal cancer.
|
Academic Article
|
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.
|
Academic Article
|
Biologic effects of platelet-derived growth factor receptor a blockade in uterine cancer.
|
Academic Article
|
MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma.
|
Academic Article
|
Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer.
|
Academic Article
|
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
|
Academic Article
|
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.
|
Academic Article
|
Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
|
Academic Article
|
Therapeutic silencing of KRAS using systemically delivered siRNAs.
|
Academic Article
|
Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.
|
Academic Article
|
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.
|
Academic Article
|
In vitro flowering associated protein changes in Dendrocalamus hamiltonii.
|
Academic Article
|
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
|
Academic Article
|
Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
|
Academic Article
|
Preclinical and clinical development of siRNA-based therapeutics.
|
Academic Article
|
STAMP2 increases oxidative stress and is critical for prostate cancer.
|
Academic Article
|
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
|
Academic Article
|
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
|
Academic Article
|
The ZNF304-integrin axis protects against anoikis in cancer.
|
Academic Article
|
Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
|
Academic Article
|
Targeting c-MYC in Platinum-Resistant Ovarian Cancer.
|
Academic Article
|
Sympathetic nervous system regulation of the tumour microenvironment.
|
Academic Article
|
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
|
Academic Article
|
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.
|
Academic Article
|
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.
|
Academic Article
|
Erythropoietin Stimulates Tumor Growth via EphB4.
|
Academic Article
|
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression.
|
Academic Article
|
Profiling Long Noncoding RNA Expression Using Custom-Designed Microarray.
|
Academic Article
|
Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
|
Academic Article
|
Role of Increased n-acetylaspartate Levels in Cancer.
|
Academic Article
|
Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.
|
Academic Article
|
Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth.
|
Academic Article
|
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.
|
Academic Article
|
?Np63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.
|
Academic Article
|
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
|
Academic Article
|
A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets.
|
Academic Article
|
Highly heterogeneous genomic landscape of uterine leiomyomas by?whole exome sequencing and genome-wide arrays.
|
Academic Article
|
Association of somatic mutations of ADAMTS genes with chemotherapy sensitivity and survival in high-grade serous ovarian carcinoma
|
Academic Article
|
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer
|
Academic Article
|
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
|
Academic Article
|
PRKCI promotes immune suppression in ovarian cancer.
|
Academic Article
|
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
|
Academic Article
|
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context.
|
Academic Article
|
Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer.
|
Academic Article
|
miRNA Deregulation in Cancer Cells and the Tumor Microenvironment.
|
Academic Article
|
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.
|
Academic Article
|
Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition.
|
Academic Article
|
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer.
|
Academic Article
|
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.
|
Academic Article
|
Coevolution of neoplastic epithelial cells and multilineage stroma via polyploid giant cells during immortalization and transformation of mullerian epithelial cells.
|
Academic Article
|
SSRI use and clinical outcomes in epithelial ovarian cancer.
|
Academic Article
|
Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
|
Academic Article
|
Association of Ovarian Tumor ?2-Adrenergic Receptor Status with Ovarian Cancer Risk Factors and Survival.
|
Academic Article
|
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells.
|
Academic Article
|
TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin.
|
Academic Article
|
microRNA Therapeutics in Cancer - An Emerging Concept.
|
Academic Article
|
MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
|
Academic Article
|
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers.
|
Academic Article
|
Calcium-mediated oxidative stress: a common mechanism in tight junction disruption by different types of cellular stress.
|
Academic Article
|
MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis.
|
Academic Article
|
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.
|
Academic Article
|
In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy.
|
Academic Article
|
Metastasis regulation by PPARD expression in cancer cells.
|
Academic Article
|
Role of Platelet-Derived Tgf?1 in the Progression of Ovarian Cancer.
|
Academic Article
|
miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
|
Academic Article
|
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
|
Academic Article
|
Chitosan Nanoparticles for miRNA Delivery.
|
Academic Article
|
Role of ADP receptors on platelets in the growth of ovarian cancer.
|
Academic Article
|
Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.
|
Academic Article
|
MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels.
|
Academic Article
|
Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.
|
Academic Article
|
Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
|
Academic Article
|
A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.
|
Academic Article
|
Association of biobehavioral factors with non-coding RNAs in cervical cancer.
|
Academic Article
|
Activating Transcription Factor 4 Modulates TGF?-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.
|
Academic Article
|
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
|
Academic Article
|
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
|
Academic Article
|
FABP4 as a key determinant of metastatic potential of ovarian cancer.
|
Academic Article
|
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
|
Academic Article
|
Shedding Light on the Dark Cancer Genomes: Long Noncoding RNAs as Novel Biomarkers and Potential Therapeutic Targets for Cancer.
|
Academic Article
|
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
|
Academic Article
|
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
|
Academic Article
|
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.
|
Academic Article
|
RNA interference-based therapy and its delivery systems.
|
Academic Article
|
Quaking orchestrates a post-transcriptional regulatory network of endothelial cell cycle progression critical to angiogenesis and metastasis.
|
Academic Article
|
GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition.
|
Academic Article
|
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4.
|
Academic Article
|
Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells.
|
Concept
|
Transcriptome
|
Concept
|
Exome
|
Concept
|
Gene Ontology
|
Academic Article
|
Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.
|
Academic Article
|
Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression.
|
Academic Article
|
6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase-2 Regulates TP53-Dependent Paclitaxel Sensitivity in Ovarian and Breast Cancers.
|
Academic Article
|
Clinical and biological significance of EZH2 expression in endometrial cancer.
|
Academic Article
|
Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.
|
Academic Article
|
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.
|
Academic Article
|
Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.
|
Academic Article
|
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors.
|
Academic Article
|
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer.
|
Academic Article
|
The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis.
|
Academic Article
|
CD8+ T cells inhibit metastasis and CXCL4 regulates its function.
|
Academic Article
|
Combined VEGFR and MAPK pathway inhibition in angiosarcoma.
|
Academic Article
|
Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy.
|
Academic Article
|
Editor's Note: Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles.
|
Academic Article
|
Gene Body Methylation of the Lymphocyte-Specific Gene CARD11 Results in Its Overexpression and Regulates Cancer mTOR Signaling.
|
Academic Article
|
Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
|
Academic Article
|
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site.
|